Free Trial
NASDAQ:PAHC

Phibro Animal Health Q1 2027 Earnings Date & Estimates

Phibro Animal Health logo
$38.30 +0.90 (+2.41%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$38.34 +0.04 (+0.10%)
As of 10/9/2026 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Phibro Animal Health is expected to report Q1 2027 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for November 5, 2026 at 9:00 AM ET.

Upcoming Earnings Announcement

Quarter
Q1 2027
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
9:00 AM ET

What Analysts Expect from Phibro Animal Health in Q1 2027

Phibro Animal Health is expected to post earnings of $0.77 per share on revenue of $381.75 million. In the same quarter a year earlier Phibro Animal Health reported $0.73 per share on revenue of $363.89 million. Phibro Animal Health last reported on August 26, 2026, posting $0.85 per share and beating the $0.7130 consensus estimate. Phibro Animal Health has beaten the consensus EPS estimate in 8 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.77
Expected Revenue
$381.75 million
Prior-Year EPS
$0.73
Prior-Year Revenue
$363.89 million
Expected EPS Growth
+5.5%
Expected Revenue Growth
+4.9%

Recent Track Record

Last Reported
Q4 2026
Last Quarter EPS
$0.85 (Beat by +$0.1370)
Last Quarter Revenue
$396.75 million
EPS Beat Rate
8 of last 8 quarters

Phibro Animal Health Q1 2027 Earnings FAQ

Phibro Animal Health (NASDAQ:PAHC) is estimated to report Q1 2027 earnings on Wednesday, November 4, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Phibro Animal Health's Q1 2027 earnings conference call is scheduled for Thursday, November 5, 2026 at 9:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Phibro Animal Health to post earnings of $0.77 per share for Q1 2027.

The consensus revenue estimate for Phibro Animal Health is $381.75 million for Q1 2027.

Phibro Animal Health Earnings Headlines

What Is Drawing Attention To Phibro Animal Health (PAHC) Today?
Is it the Right Time to Add Phibro Stock to Your Portfolio?
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
See More Phibro Animal Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Phibro Animal Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Phibro Animal Health and other key companies, straight to your email.

About Phibro Animal Health

Phibro Animal Health (NASDAQ:PAHC) (NASDAQ: PAHC) develops, manufactures and distributes products that support animal health, nutrition and performance. The company serves livestock producers, veterinarians, feed manufacturers and other customers across the food-animal and companion-animal markets.

Its portfolio includes animal health products such as vaccines, medicated feed additives and other solutions used to help prevent and manage disease. Phibro also provides mineral nutrition products, feed additives and performance solutions designed to support animal growth, feed efficiency, health and productivity.

Phibro Animal Health traces its roots to 1916 and operates internationally, serving customers in the United States and markets around the world. Its products are used in the production of poultry, swine, cattle and aquaculture species, as well as in companion-animal applications. The company sells through direct commercial operations, distributors and strategic partners.

View Phibro Animal Health Profile